Why is Gennex Lab. falling/rising?

As of 03-Nov, Gennex Laboratories Ltd is experiencing a decline in its stock price, currently at 15.46, which reflects a decrease of 0.97 or 5.9%. The stock has underperformed its sector by 7.2% today, and its delivery volume has significantly dropped by 81.03% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has decreased by 5.44%, while it has shown a more substantial decline of 26.38% over the past year, contrasting with a 5.34% gain in the broader market. Although the company has a low debt-to-equity ratio and has seen healthy long-term growth in operating profit, its return on equity is relatively low at 8.68%, which suggests inefficiencies in management and profitability.
In the broader market context, Gennex Laboratories Ltd's recent performance has been notably weaker than the benchmark, with the Sensex only declining by 0.94% over the same week. The stock's year-to-date performance is also concerning, as it has fallen by 5.39%, while the market has gained 7.47%. Despite the company's attractive valuation and a PEG ratio of 1.6, the negative sentiment surrounding its flat results and reliance on non-operating income has contributed to its underperformance. Overall, the combination of declining investor interest and poor management efficiency has led to the stock's current downward trend.